Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study history now indicates enrollment is closed, and the record version has been updated to v3.6.0 (removing the prior v3.5.5).SummaryDifference0.3%

- Check17 days agoChange DetectedThe footer's revision tag was updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page footer revision label has been updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.0%

- Check53 days agoChange DetectedA new revision entry, v3.5.3, was added to the study's history, replacing the previous v3.5.2. This updates the record history to reflect an additional iteration of the record.SummaryDifference0.0%

- Check61 days agoChange DetectedUpdated the site revision indicator from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.